Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Reflections on and future of hematologic malignancies research in the Veterans Health Administration.

Friedman DR, Carson KR, Weinberg JB.

Semin Oncol. 2019 Aug - Oct;46(4-5):346-350. doi: 10.1053/j.seminoncol.2019.09.004. Epub 2019 Oct 22. Review.

PMID:
31699443
2.

Metformin Use and Pancreatic Cancer Survival among non-Hispanic White and African American US Veterans with Diabetes Mellitus.

Toriola AT, Luo S, Thomas TS, Drake BF, Chang SH, Sanfilippo KM, Carson KR.

Cancer Epidemiol Biomarkers Prev. 2019 Nov 4. pii: cebp.0781.2019. doi: 10.1158/1055-9965.EPI-19-0781. [Epub ahead of print]

PMID:
31685560
3.

Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma.

Thomas TS, Luo S, Reagan PM, Keller JW, Sanfilippo KM, Carson KR.

J Geriatr Oncol. 2019 Oct 24. pii: S1879-4068(19)30061-X. doi: 10.1016/j.jgo.2019.09.009. [Epub ahead of print]

PMID:
31668826
4.

Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.

Chang SH, Gumbel J, Luo S, Thomas TS, Sanfilippo KM, Luo J, Colditz GA, Carson KR.

Cancer Epidemiol Biomarkers Prev. 2019 Dec;28(12):2055-2061. doi: 10.1158/1055-9965.EPI-19-0132. Epub 2019 Sep 9.

PMID:
31501149
5.

Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score.

Sanfilippo KM, Luo S, Wang TF, Fiala M, Schoen M, Wildes TM, Mikhael J, Kuderer NM, Calverley DC, Keller J, Thomas T, Carson KR, Gage BF.

Am J Hematol. 2019 Nov;94(11):1176-1184. doi: 10.1002/ajh.25603. Epub 2019 Aug 19.

PMID:
31379000
6.

Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma.

Andrews JM, Schmidt JA, Carson KR, Musiek AC, Mehta-Shah N, Payton JE.

EBioMedicine. 2019 Aug;46:170-183. doi: 10.1016/j.ebiom.2019.07.053. Epub 2019 Jul 26.

7.

Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response.

Chen L, Carson KR, Staser KW, Mehta-Shah N, Schaffer A, Rosman IS, Musiek A.

JAMA Dermatol. 2019 May 29. doi: 10.1001/jamadermatol.2019.0369. [Epub ahead of print] No abstract available.

PMID:
31141114
8.

The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.

Park SI, Horwitz SM, Foss FM, Pinter-Brown LC, Carson KR, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Shustov AR; COMPLETE Investigators.

Cancer. 2019 May 1;125(9):1507-1517. doi: 10.1002/cncr.31861. Epub 2019 Jan 29. Erratum in: Cancer. 2019 Nov 1;125(21):3893.

PMID:
30694529
9.

Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.

Khozin S, Carson KR, Zhi J, Tucker M, Lee SE, Light DE, Curtis MD, Bralic M, Kaganman I, Gossai A, Hofmeister P, Torres AZ, Miksad RA, Blumenthal GM, Pazdur R, Abernethy AP.

Oncologist. 2019 May;24(5):648-656. doi: 10.1634/theoncologist.2018-0307. Epub 2018 Dec 27.

PMID:
30591549
10.

Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors.

O'Connor JM, Seidl-Rathkopf K, Torres AZ, You P, Carson KR, Ross JS, Gross CP.

Oncologist. 2018 Nov;23(11):1388-1390. doi: 10.1634/theoncologist.2017-0673. Epub 2018 Jul 16.

11.

Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials.

O'Connor JM, Fessele KL, Steiner J, Seidl-Rathkopf K, Carson KR, Nussbaum NC, Yin ES, Adelson KB, Presley CJ, Chiang AC, Ross JS, Abernethy AP, Gross CP.

JAMA Oncol. 2018 Aug 1;4(8):e180798. doi: 10.1001/jamaoncol.2018.0798. Epub 2018 Aug 9.

12.

Leveraging real-world data to move toward more personalized fertility treatment.

Jungheim ES, Carson KR.

Fertil Steril. 2018 Apr;109(4):608-609. doi: 10.1016/j.fertnstert.2018.01.036. No abstract available.

PMID:
29653708
13.

Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.

Hsi ED, Horwitz SM, Carson KR, Pinter-Brown LC, Rosen ST, Pro B, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Collie AM, Gruver AM, Grzywacz BJ, Turakhia S, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM.

Clin Lymphoma Myeloma Leuk. 2017 Apr;17(4):193-200. doi: 10.1016/j.clml.2016.10.001. Epub 2017 Jan 10.

PMID:
28209473
14.

Reply to S. Suissa et al.

Sanfilippo KM, Luo S, Gage BF, Carson KR.

J Clin Oncol. 2017 Apr 20;35(12):1378-1379. doi: 10.1200/JCO.2016.71.3958. Epub 2017 Feb 6. No abstract available.

PMID:
28165899
15.

Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.

Krysiak K, Gomez F, White BS, Matlock M, Miller CA, Trani L, Fronick CC, Fulton RS, Kreisel F, Cashen AF, Carson KR, Berrien-Elliott MM, Bartlett NL, Griffith M, Griffith OL, Fehniger TA.

Blood. 2017 Jan 26;129(4):473-483. doi: 10.1182/blood-2016-07-729954. Epub 2016 Nov 14.

16.

Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study.

Chang SH, Luo S, Thomas TS, O'Brian KK, Colditz GA, Carlsson NP, Carson KR.

J Natl Cancer Inst. 2016 Dec 31;109(5). doi: 10.1093/jnci/djw264. Print 2017 May.

17.

A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.

Carson KR, Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta MA, Shustov AR, Advani RH, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM.

Cancer. 2017 Apr 1;123(7):1174-1183. doi: 10.1002/cncr.30416. Epub 2016 Dec 2.

18.

Weight change trends and overall survival in United States veterans with follicular lymphoma treated with chemotherapy.

Xiao DY, Luo S, O'Brian K, Liu W, Carson KR.

Leuk Lymphoma. 2017 Apr;58(4):851-858. doi: 10.1080/10428194.2016.1217526. Epub 2016 Sep 26.

19.

Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.

Bennett CL, Berger JR, Sartor O, Carson KR, Hrushesky WJ, Georgantopoulos P, Raisch DW, Norris LB, Armitage JO.

Br J Haematol. 2018 Jan;180(2):301-304. doi: 10.1111/bjh.14322. Epub 2016 Sep 21. No abstract available.

PMID:
27649938
20.

Statins Are Associated With Reduced Mortality in Multiple Myeloma.

Sanfilippo KM, Keller J, Gage BF, Luo S, Wang TF, Moskowitz G, Gumbel J, Blue B, O'Brian K, Carson KR.

J Clin Oncol. 2016 Nov 20;34(33):4008-4014. doi: 10.1200/JCO.2016.68.3482. Epub 2016 Sep 30.

21.

Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans.

Xiao DY, Luo S, O'Brian K, Sanfilippo KM, Ganti A, Riedell P, Lynch RC, Liu W, Kahl BS, Cashen AF, Fehniger TA, Carson KR.

J Natl Cancer Inst. 2016 Jul 5;108(11). doi: 10.1093/jnci/djw145. Print 2016 Nov.

22.

Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy.

Xiao DY, Luo S, O'Brian K, Ganti A, Riedell P, Sanfilippo KM, Lynch RC, Liu W, Carson KR.

Am J Hematol. 2016 Oct;91(10):1002-7. doi: 10.1002/ajh.24465. Epub 2016 Jul 22.

23.

Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.

Sanfilippo KM, Wang TF, Gage BF, Luo S, Riedell P, Carson KR.

Thromb Res. 2016 Jul;143:86-90. doi: 10.1016/j.thromres.2016.05.008. Epub 2016 May 11.

24.

Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.

Burudpakdee C, Lin HM, Wang W, Seetasith A, Zhu Y, Bonthapally V, Carson KR.

J Med Econ. 2016 Oct;19(10):965-72. doi: 10.1080/13696998.2016.1187622. Epub 2016 May 26.

PMID:
27152635
25.

Identifying existing Choosing Wisely recommendations of high relevance and importance to hematology.

Hicks LK, Rajasekhar A, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Sarode R, Wood WA.

Am J Hematol. 2016 Aug;91(8):787-92. doi: 10.1002/ajh.24412. Epub 2016 Jun 8.

26.

Race-based differences in routine cytogenetic profiles of patients with multiple myeloma.

Blue BJ, Luo S, Sanfilippo KM, Ganti A, Gumbel J, O'Brian K, Carson KR.

Br J Haematol. 2017 Jan;176(2):322-324. doi: 10.1111/bjh.13950. Epub 2016 Feb 16. No abstract available.

27.

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.

Advani RH, Ansell SM, Lechowicz MJ, Beaven AW, Loberiza F, Carson KR, Evens AM, Foss F, Horwitz S, Pro B, Pinter-Brown LC, Smith SM, Shustov AR, Savage KJ, Vose JM.

Br J Haematol. 2016 Feb;172(4):535-44. doi: 10.1111/bjh.13855. Epub 2015 Dec 2.

28.

Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria.

Rashidi A, Oak E, Carson KR, Wagner-Johnston ND, Kreisel F, Bartlett NL.

Leuk Lymphoma. 2016 May;57(5):1191-3. doi: 10.3109/10428194.2015.1096356. Epub 2015 Oct 20. No abstract available.

PMID:
26397936
29.

Risk-adapted strategies for the treatment of Hodgkin lymphoma.

Keller J, Carson KR.

Expert Opin Drug Saf. 2015 Oct;14(10):1519-30. doi: 10.1517/14740338.2015.1084285. Review.

PMID:
26394771
30.

Toll-like receptor 2 activators modulate oral tolerance in mice.

Tunis MC, Dawod B, Carson KR, Veinotte LL, Marshall JS.

Clin Exp Allergy. 2015 Nov;45(11):1690-702. doi: 10.1111/cea.12605.

31.

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.

Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO; American Society of Clinical Oncology.

J Clin Oncol. 2015 Oct 1;33(28):3199-212. doi: 10.1200/JCO.2015.62.3488. Epub 2015 Jul 13. Review.

PMID:
26169616
32.

Short- and Long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy.

O'Brian K, Luo S, Ganti A, Riedell P, Lynch RC, Roop R, Sanfilippo KM, Liu W, Colditz GA, Carson KR.

Leuk Lymphoma. 2016 Feb;57(2):313-319. doi: 10.3109/10428194.2015.1056183. Epub 2015 Jul 25.

33.

Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.

Chang SH, Luo S, O'Brian KK, Thomas TS, Colditz GA, Carlsson NP, Carson KR.

Lancet Haematol. 2015 Jan;2(1):e30-6. Erratum in: Lancet Haematol. 2015 Feb;2(2):e54.

34.

Variability in the practice of fertility preservation for patients with cancer.

Reynolds KA, Grindler NM, Rhee JS, Cooper AR, Ratts VS, Carson KR, Jungheim ES.

PLoS One. 2015 May 26;10(5):e0127335. doi: 10.1371/journal.pone.0127335. eCollection 2015.

35.

High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma.

Wildes TM, Finney JD, Fiala M, Gao F, Vij R, Stockerl-Goldstein K, Carson KR, Mikhael J, Colditz G.

Bone Marrow Transplant. 2015 Aug;50(8):1075-82. doi: 10.1038/bmt.2015.106. Epub 2015 May 11.

36.

Five hematologic tests and treatments to question.

Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):599-603. doi: 10.1182/asheducation-2014.1.599. Epub 2014 Nov 18.

PMID:
25696917
37.

Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma.

Carson KR, Riedell P, Lynch R, Nabhan C, Wildes TM, Liu W, Ganti A, Roop R, Sanfilippo KM, O'Brian K, Liu J, Bartlett NL, Cashen A, Wagner-Johnston N, Fehniger TA, Colditz GA.

J Geriatr Oncol. 2015 May;6(3):211-8. doi: 10.1016/j.jgo.2015.01.003. Epub 2015 Jan 19.

38.

Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data.

Sanfilippo KM, Wang TF, Gage BF, Liu W, Carson KR.

Thromb Res. 2015 Apr;135(4):616-20. doi: 10.1016/j.thromres.2015.01.012. Epub 2015 Jan 14.

39.

Five hematologic tests and treatments to question.

Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA.

Blood. 2014 Dec 4;124(24):3524-8. doi: 10.1182/blood-2014-09-599399.

PMID:
25472968
40.

Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: diagnostic implications.

Hsi AC, Lee SJ, Rosman IS, Carson KR, Kelley A, Viele V, Pang X, Musiek A, Schaffer A.

J Am Acad Dermatol. 2015 Jan;72(1):159-67. doi: 10.1016/j.jaad.2014.09.022. Epub 2014 Oct 18.

PMID:
25440432
41.
42.

Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone.

Ganti A, Liu W, Luo S, Sanfilippo KM, Roop R, Lynch R, Riedell P, O'Brian K, Colditz GA, Carson KR.

Br J Haematol. 2014 Dec;167(5):699-702. doi: 10.1111/bjh.13026. Epub 2014 Jul 15. No abstract available.

43.

Deletion of potD, encoding a putative spermidine-binding protein, results in a complex phenotype in Legionella pneumophila.

Nasrallah GK, Abdelhady H, Tompkins NP, Carson KR, Garduño RA.

Int J Med Microbiol. 2014 Jul;304(5-6):703-16. doi: 10.1016/j.ijmm.2014.05.004. Epub 2014 May 15.

PMID:
24928741
44.

Surveillance imaging for lymphoma: pros and cons.

Lynch RC, Zelenetz AD, Armitage JO, Carson KR.

Am Soc Clin Oncol Educ Book. 2014:e388-95. doi: 10.14694/EdBook_AM.2014.34.e388. Review.

45.

A drug safety evaluation of rituximab and risk of hepatitis B.

Riedell P, Carson KR.

Expert Opin Drug Saf. 2014 Jul;13(7):977-87. doi: 10.1517/14740338.2014.918948. Epub 2014 May 12. Review.

PMID:
24821316
46.

The skinny on obesity and plasma cell myeloma: a review of the literature.

Carson KR, Bates ML, Tomasson MH.

Bone Marrow Transplant. 2014 Aug;49(8):1009-15. doi: 10.1038/bmt.2014.71. Epub 2014 May 12. Review.

PMID:
24820216
47.

Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.

Carson KR, Newsome SD, Kim EJ, Wagner-Johnston ND, von Geldern G, Moskowitz CH, Moskowitz AJ, Rook AH, Jalan P, Loren AW, Landsburg D, Coyne T, Tsai D, Raisch DW, Norris LB, Bookstaver PB, Sartor O, Bennett CL.

Cancer. 2014 Aug 15;120(16):2464-71. doi: 10.1002/cncr.28712. Epub 2014 Apr 25.

48.

The ASH Choosing Wisely®campaign: five hematologic tests and treatments to question.

Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA.

Hematology Am Soc Hematol Educ Program. 2013;2013:9-14. doi: 10.1182/asheducation-2013.1.9.

PMID:
24319155
49.

The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question.

Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA.

Blood. 2013 Dec 5;122(24):3879-83. doi: 10.1182/blood-2013-07-518423. Epub 2013 Dec 4.

PMID:
24307720
50.

A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma.

Evens AM, Carson KR, Kolesar J, Nabhan C, Helenowski I, Islam N, Jovanovic B, Barr PM, Caimi PF, Gregory SA, Gordon LI.

Ann Oncol. 2013 Dec;24(12):3076-81. doi: 10.1093/annonc/mdt414. Epub 2013 Oct 20. Erratum in: Ann Oncol. 2014 Jul;25(7):1449.

Supplemental Content

Loading ...
Support Center